イリノイ州における慢性腎臓病の臨床試験
イリノイ州内の拠点で、慢性腎臓病に関する17件の研究が参加者を募集しています。
イリノイ州内の都市
公式研究テキスト（英語）
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Accellacare - DuPage, Lombard
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Champaign
- Research Site, Maywood
- Research Site, Rockford
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
- Comprehensive Transplant Center, Chicago
被験者募集中観察研究
18歳〜70歳 · 全性別 · 2026/09/25更新 · NCT05106387A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Oak Brook
- Research Site, Rockford
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/24更新 · NCT07624305A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/16更新 · NCT07107945Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Research by Design, LLC - Internal Medicine, Chicago
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/11更新 · NCT07271186A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Champaign
- Research Site, Chicago
- Research Site, Chicago
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07753993Breakthrough - T1DM and Chronic Kidney Disease
- The University of Chicago, Chicago
被験者募集中第1/2相
18歳〜70歳 · 全性別 · 2026/08/20更新 · NCT07592000Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
被験者募集中早期第1相
12歳〜25歳 · 全性別 · 2026/08/19更新 · NCT06430684A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
- Research Site, Chicago
被験者募集中第1相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/08/12更新 · NCT07024823Study of BHV-1400 in IgA Nephropathy
- Site-009, Hinsdale
被験者募集中第1相
18歳〜65歳 · 全性別 · 2026/06/23更新 · NCT07054684Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
- Northwestern Memorial Hospital, Chicago
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/22更新 · NCT01644903Empagliflozin Treatment in Kidney Transplant Recipients
- Edward Hines Jr. VA Hospital, Hines, IL, Hines
被験者募集中第4相
19歳以上 · 全性別 · 2026/04/21更新 · NCT06013865Kidney Precision Medicine Project
- University of Illinois Chicago, Chicago
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/14更新 · NCT04334707Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
- Northwestern Memorial Hospital, Chicago
被験者募集中第1/2相
40歳〜70歳 · 全性別 · 2026/03/27更新 · NCT06878560Transformative Research in Diabetic Nephropathy
- Northwestern University, Chicago
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2026/02/27更新 · NCT02986984Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
- University of Chicago Medical Center, Chicago
被験者募集中
18歳〜70歳 · 全性別 · 2025/11/14更新 · NCT06397456ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。